カテゴリー： QYResearch, 世界

神経障害治療法の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Neurologic Disorders Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18749）・商品コード：DATA909X18749
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：92
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、神経障害治療法の世界市場について調査・分析し、神経障害治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（中枢神経系（CNS）、末梢神経系（PNS））、用途別（麻痺、筋力低下、協調不良、感覚喪失、発作、混乱、痛み、意識レベル変化）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の神経障害治療法市場動向
・主要企業別マーケットシェア
・神経障害治療法の種類別市場規模2014-2019
（中枢神経系（CNS）、末梢神経系（PNS））
・神経障害治療法の用途別市場規模2014-2019
（麻痺、筋力低下、協調不良、感覚喪失、発作、混乱、痛み、意識レベル変化）
・神経障害治療法の北米市場：主要企業・種類別/用途別市場規模
・神経障害治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模
・神経障害治療法の中国市場：主要企業・種類別/用途別市場規模
・神経障害治療法の日本国内市場：主要企業・種類別/用途別市場規模
・神経障害治療法の東南アジア市場：主要企業・種類別/用途別市場規模
・神経障害治療法のインド市場：主要企業・種類別/用途別市場規模
・神経障害治療法の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Biogen Inc.、F. Hoffmann-La Roche Ltd.、Johnson & Johnson Services Inc.、Novartis AG、Pfizer Inc.）
・神経障害治療法の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.The early diagnosis of neurodegenerative indications is difficult because of their complex nature, fast progression, and lack of effective diagnostic processes. This has encouraged researchers to focus on the development of novel biomarkers that can accurately detect neurodegenerative indications.
In 2018, the global Neurologic Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Neurologic Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neurologic Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Biogen Inc.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
…

Market segment by Type, the product can be split into
Central Nervous System (CNS)
Peripheral Nervous System (PNS)

Market segment by Application, split into
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Neurologic Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Neurologic Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Neurologic Disorders Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Central Nervous System (CNS)
1.4.3 Peripheral Nervous System (PNS)
1.5 Market by Application
1.5.1 Global Neurologic Disorders Therapeutics Market Share by Application (2019-2025)
1.5.2 Paralysis
1.5.3 Muscle Weakness
1.5.4 Poor Coordination
1.5.5 Loss of Sensation
1.5.6 Seizures
1.5.7 Confusion
1.5.8 Pain and Altered Levels of Consciousness
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Neurologic Disorders Therapeutics Market Size
2.2 Neurologic Disorders Therapeutics Growth Trends by Regions
2.2.1 Neurologic Disorders Therapeutics Market Size by Regions (2019-2025)
2.2.2 Neurologic Disorders Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Neurologic Disorders Therapeutics Market Size by by Players
3.1.1 Global Neurologic Disorders Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Neurologic Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Neurologic Disorders Therapeutics Key Players Head office and Area Served
3.3 Key Players Neurologic Disorders Therapeutics Product/Solution/Service
3.4 Date of Enter into Neurologic Disorders Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Neurologic Disorders Therapeutics Market Size by Type (2014-2019)
4.2 Global Neurologic Disorders Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Neurologic Disorders Therapeutics Market Size (2014-2019)
5.2 Neurologic Disorders Therapeutics Key Players in North America
5.3 North America Neurologic Disorders Therapeutics Market Size by Type
5.4 North America Neurologic Disorders Therapeutics Market Size by Application

6 Europe
6.1 Europe Neurologic Disorders Therapeutics Market Size (2014-2019)
6.2 Neurologic Disorders Therapeutics Key Players in Europe
6.3 Europe Neurologic Disorders Therapeutics Market Size by Type
6.4 Europe Neurologic Disorders Therapeutics Market Size by Application

7 China
7.1 China Neurologic Disorders Therapeutics Market Size (2014-2019)
7.2 Neurologic Disorders Therapeutics Key Players in China
7.3 China Neurologic Disorders Therapeutics Market Size by Type
7.4 China Neurologic Disorders Therapeutics Market Size by Application

8 Japan
8.1 Japan Neurologic Disorders Therapeutics Market Size (2014-2019)
8.2 Neurologic Disorders Therapeutics Key Players in Japan
8.3 Japan Neurologic Disorders Therapeutics Market Size by Type
8.4 Japan Neurologic Disorders Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Neurologic Disorders Therapeutics Market Size (2014-2019)
9.2 Neurologic Disorders Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Neurologic Disorders Therapeutics Market Size by Type
9.4 Southeast Asia Neurologic Disorders Therapeutics Market Size by Application

10 India
10.1 India Neurologic Disorders Therapeutics Market Size (2014-2019)
10.2 Neurologic Disorders Therapeutics Key Players in India
10.3 India Neurologic Disorders Therapeutics Market Size by Type
10.4 India Neurologic Disorders Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Neurologic Disorders Therapeutics Market Size (2014-2019)
11.2 Neurologic Disorders Therapeutics Key Players in Central & South America
11.3 Central & South America Neurologic Disorders Therapeutics Market Size by Type
11.4 Central & South America Neurologic Disorders Therapeutics Market Size by Application

12 International Players Profiles
12.1 Biogen Inc.
12.1.1 Biogen Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neurologic Disorders Therapeutics Introduction
12.1.4 Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2014-2019))
12.1.5 Biogen Inc. Recent Development
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 F. Hoffmann-La Roche Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neurologic Disorders Therapeutics Introduction
12.2.4 F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Ltd. Recent Development
12.3 Johnson & Johnson Services Inc.
12.3.1 Johnson & Johnson Services Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neurologic Disorders Therapeutics Introduction
12.3.4 Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2014-2019)
12.3.5 Johnson & Johnson Services Inc. Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neurologic Disorders Therapeutics Introduction
12.4.4 Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neurologic Disorders Therapeutics Introduction
12.5.4 Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2014-2019)
12.5.5 Pfizer Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Neurologic Disorders Therapeutics Key Market Segments
Table Key Players Neurologic Disorders Therapeutics Covered
Table Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Central Nervous System (CNS) Figures
Table Key Players of Central Nervous System (CNS)
Figuer Peripheral Nervous System (PNS) Figures
Table Key Players of Peripheral Nervous System (PNS)
Table Global Neurologic Disorders Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Neurologic Disorders Therapeutics Market Share by Application in 2018 & 2025
Figure Paralysis Case Studies
Figure Muscle Weakness Case Studies
Figure Poor Coordination Case Studies
Figure Loss of Sensation Case Studies
Figure Seizures Case Studies
Figure Confusion Case Studies
Figure Pain and Altered Levels of Consciousness Case Studies
Figure Neurologic Disorders Therapeutics Report Years Considered
Figure Global Neurologic Disorders Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Neurologic Disorders Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Neurologic Disorders Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Neurologic Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Neurologic Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Neurologic Disorders Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Neurologic Disorders Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Neurologic Disorders Therapeutics Market Share by by Players (2014-2019)
Figure Global Neurologic Disorders Therapeutics Market Share by by Players in 2018
Table Global Neurologic Disorders Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neurologic Disorders Therapeutics Product/Solution/Service
Table Date of Enter into Neurologic Disorders Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neurologic Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Neurologic Disorders Therapeutics Market Size Share by Type (2014-2019)
Figure Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Neurologic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Neurologic Disorders Therapeutics Market Size Share by Application (2014-2019)
Figure Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Neurologic Disorders Therapeutics Revenue Market Share by Application in 2018
Figure North America Neurologic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Neurologic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Neurologic Disorders Therapeutics Market Share (2018-2019)
Table North America Neurologic Disorders Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Neurologic Disorders Therapeutics Market Share by Type 2014-2019
Table North America Neurologic Disorders Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Neurologic Disorders Therapeutics Market Share by Application 2014-2019
Figure Europe Neurologic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Neurologic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Neurologic Disorders Therapeutics Market Share (2018-2019)
Table Europe Neurologic Disorders Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Neurologic Disorders Therapeutics Market Share by Type 2014-2019
Table Europe Neurologic Disorders Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Neurologic Disorders Therapeutics Market Share by Application 2014-2019
Figure China Neurologic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Neurologic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Neurologic Disorders Therapeutics Market Share (2018-2019)
Table China Neurologic Disorders Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Neurologic Disorders Therapeutics Market Share by Type 2014-2019
Table China Neurologic Disorders Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Neurologic Disorders Therapeutics Market Share by Application 2014-2019
Figure Japan Neurologic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Neurologic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Neurologic Disorders Therapeutics Market Share (2018-2019)
Table Japan Neurologic Disorders Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Neurologic Disorders Therapeutics Market Share by Type 2014-2019
Table Japan Neurologic Disorders Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Neurologic Disorders Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Neurologic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Neurologic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Neurologic Disorders Therapeutics Market Share (2018-2019)
Table Southeast Asia Neurologic Disorders Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Neurologic Disorders Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Neurologic Disorders Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Neurologic Disorders Therapeutics Market Share by Application 2014-2019
Figure India Neurologic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Neurologic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Neurologic Disorders Therapeutics Market Share (2018-2019)
Table India Neurologic Disorders Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Neurologic Disorders Therapeutics Market Share by Type 2014-2019
Table India Neurologic Disorders Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Neurologic Disorders Therapeutics Market Share by Application 2014-2019
Figure Central & South America Neurologic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Neurologic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Neurologic Disorders Therapeutics Market Share (2018-2019)
Table Central & South America Neurologic Disorders Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Neurologic Disorders Therapeutics Market Share by Type 2014-2019
Table Central & South America Neurologic Disorders Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Neurologic Disorders Therapeutics Market Share by Application 2014-2019
Table Biogen Inc. Company Details
Table Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business 2014-2019 (Million US$)
Figure Biogen Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2014-2019)
Table Biogen Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Johnson & Johnson Services Inc. Company Details
Table Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business 2014-2019 (Million US$)
Figure Johnson & Johnson Services Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2014-2019)
Table Johnson & Johnson Services Inc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Neurologic Disorders Therapeutics Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2014-2019)
Table Novartis AG Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Global Neurologic Disorders Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Neurologic Disorders Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Neurologic Disorders Therapeutics Market Size Share by Regions in 2025
Figure North America Neurologic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Neurologic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Neurologic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Neurologic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Neurologic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Neurologic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Neurologic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Neurologic Disorders Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Neurologic Disorders Therapeutics Market Size by Product (2019-2025)
Figure Global Neurologic Disorders Therapeutics Market Size by Product in 2025
Table Global Neurologic Disorders Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Neurologic Disorders Therapeutics Market Size by Application (2019-2025)
Figure Global Neurologic Disorders Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Biogen Inc.、F. Hoffmann-La Roche Ltd.、Johnson & Johnson Services Inc.、Novartis AG、Pfizer Inc.

★調査レポート[神経障害治療法の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18749)販売に関する免責事項を必ずご確認ください。
★調査レポート[神経障害治療法の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 遺伝性疾患用遺伝子治療の世界市場：規模・現状・予測2019-2025
    DATA909X18502 / QYResearch / 2019年11月25日 / ※当調査レポートでは、遺伝性疾患用遺伝子治療の世界市場について調査・分析し、遺伝性疾患用遺伝子治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（眼科疾患、血液疾患、中枢神経系疾患、筋肉疾患、その他）、用途別（病院、診療所、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の遺伝性疾患用遺伝子治療市場動向 ・主要企業別マーケットシェア ・遺伝性疾患用遺伝子治療の種類別市場規模2014-2019 （眼科疾患、血液疾患、中枢神経系疾患、筋肉疾患、その他） ・遺伝性疾患用遺伝子治療の用途別市場規模2014-2019 （病院、診療所、研究所、その他） ・遺伝性疾患用遺伝子治療の北米市場：主要企業・種類別/用途別市場規模 ・遺伝性疾患用遺伝子治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders. In 2018, the global Gene Therapy for Inherited Genetic Disorders market size was xx million US$ and it is...

    • ◆H&Iグローバルリサーチのお客様（例）◆